Cargando…

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma

As aldehyde dehydrogenase (ALDH) is a novel stem cell marker, increasing studies have confirmed that high ALDH activity promotes tumorigenesis and progression in cancers. Some preliminary studies have found that ALDH1A3 may play an important role in glioma malignant progression, but so far there was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guanzhang, Li, Yiming, Liu, Xing, Wang, Zheng, Zhang, Chuanbao, Wu, Fan, Jiang, Haoyu, Zhang, Wenlong, Bao, Zhaoshi, Wang, Yongzhi, Cai, Jinquan, Zhao, Liang, Kahlert, Ulf D., Jiang, Tao, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290011/ https://www.ncbi.nlm.nih.gov/pubmed/30538217 http://dx.doi.org/10.1038/s41419-018-1232-3

Ejemplares similares

ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion
por: Zhang, Wenlong, et al.
Publicado: (2015)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
por: Ding, Yiming, et al.
Publicado: (2022)

ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients
por: Wang, Shangqian, et al.
Publicado: (2020)

Long-term efficacy of surgical resection with or without adjuvant therapy for treatment of secondary glioblastoma in adults
por: Huang, Ruoyu, et al.
Publicado: (2020)

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution
por: Li, Rui, et al.
Publicado: (2015)

Functional clustering analysis identifies specific subtypes of aldehyde dehydrogenase associated with glioma immunity
por: Wang, Di, et al.
Publicado: (2021)

BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas
por: Bao, Zhaoshi, et al.
Publicado: (2013)

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021)

HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation
por: Cheng, Wen, et al.
Publicado: (2015)

Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
por: Wang, Hongjun, et al.
Publicado: (2015)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples
por: Cai, Jinquan, et al.
Publicado: (2014)

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
por: Li, Guanzhang, et al.
Publicado: (2019)

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
por: Yan, Wei, et al.
Publicado: (2012)

Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas
por: Yang, Fan, et al.
Publicado: (2017)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021)

RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020)

KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4
por: Sun, Lihua, et al.
Publicado: (2016)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022)

Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance
por: Cai, Jinquan, et al.
Publicado: (2015)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020)

The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer
por: Cai, Yuan, et al.
Publicado: (2022)

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
por: Cheng, Wen, et al.
Publicado: (2015)

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients
por: Wang, Zheng, et al.
Publicado: (2016)

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
por: Maciaczyk, D, et al.
Publicado: (2017)

New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis
por: Li, Lianwang, et al.
Publicado: (2021)

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
por: Wang, Qixue, et al.
Publicado: (2018)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
por: Shi, Zhong-Fang, et al.
Publicado: (2023)

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
por: Fan, Wenhua, et al.
Publicado: (2022)

ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis
por: Wu, Yang, et al.
Publicado: (2022)

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma
por: Wang, Zeyu, et al.
Publicado: (2022)

PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression
por: Wang, Tao, et al.
Publicado: (2023)

Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
por: Koch, Katharina, et al.
Publicado: (2016)

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients
por: Regnery, Sebastian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_idkpuha5emdgt4u0fcuiqjknef